XSHE000691
Market cap173mUSD
Dec 23, Last price
3.92CNY
1D
-9.89%
1Q
-7.33%
Jan 2017
-63.19%
Name
Gansu Yatai Industrial Development Co Ltd
Chart & Performance
Profile
Gansu Yatai Industrial Developent Co., Ltd. engages in the research, development, production, and sales of fine chemical products. It also offers pharmaceutical intermediates and pesticide intermediates. The company was formerly known as Hainan Yatai Industrial Development Co., Ltd. and changed its name to Gansu Yatai Industrial Developent Co., Ltd. in December 2021. The company was founded in 1996 and is based in Lanzhou, China. Gansu Yatai Industrial Developent Co., Ltd. is a subsidiary of Lanzhou Asia-Pacific Industry & Trade Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 370,613 -32.39% | 548,196 5.11% | 521,560 96.25% | |||||||
Cost of revenue | 366,448 | 488,489 | 431,753 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 4,165 | 59,707 | 89,807 | |||||||
NOPBT Margin | 1.12% | 10.89% | 17.22% | |||||||
Operating Taxes | (6,963) | 2,207 | 7,116 | |||||||
Tax Rate | 3.70% | 7.92% | ||||||||
NOPAT | 11,128 | 57,500 | 82,691 | |||||||
Net income | (104,277) -728.38% | 16,595 -61.45% | 43,041 37.38% | |||||||
Dividends | (7,840) | |||||||||
Dividend yield | 0.48% | |||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 144,723 | 114,750 | 117,885 | |||||||
Long-term debt | 3,971 | 30 | 50 | |||||||
Deferred revenue | 836 | 988 | 1,140 | |||||||
Other long-term liabilities | 1 | 30 | 50 | |||||||
Net debt | 105,402 | 83,654 | 44,273 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 21,002 | 26,470 | 66,130 | |||||||
CAPEX | (7,639) | |||||||||
Cash from investing activities | (7,620) | |||||||||
Cash from financing activities | (3,944) | |||||||||
FCF | 30,753 | 20,540 | 14,833 | |||||||
Balance | ||||||||||
Cash | 40,694 | 31,126 | 47,661 | |||||||
Long term investments | 2,597 | 2 | 26,000 | |||||||
Excess cash | 24,761 | 3,716 | 47,583 | |||||||
Stockholders' equity | 89,649 | 589,906 | 576,508 | |||||||
Invested Capital | 317,893 | 422,513 | 369,362 | |||||||
ROIC | 3.01% | 14.52% | 25.04% | |||||||
ROCE | 1.20% | 13.85% | 21.25% | |||||||
EV | ||||||||||
Common stock shares outstanding | 323,270 | 323,270 | 323,270 | |||||||
Price | 5.07 11.67% | 4.54 -4.22% | 4.74 3.49% | |||||||
Market cap | 1,638,979 11.67% | 1,467,646 -4.22% | 1,532,300 3.49% | |||||||
EV | 1,899,318 | 1,724,535 | 1,740,404 | |||||||
EBITDA | 40,629 | 98,266 | 126,550 | |||||||
EV/EBITDA | 46.75 | 17.55 | 13.75 | |||||||
Interest | 12,497 | 12,029 | 15,075 | |||||||
Interest/NOPBT | 300.04% | 20.15% | 16.79% |